DPP9 and Merkel cell skin cancer: To further verify that the ability of certain HATis to repress MCPyV+ MCC is due to the targeted downregulation of viral oncoprotein expression and not due to off-target effects, the same inhibitors were used to treat the MCPyV- MCC cell line MCC-13 (Fig 9B).